<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 21.4: Phase 3: Anti-Inflammatory & Therapeutic Interventions (The 'A')</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/GREEN theme for Treatment Planning */
        .module-header {
            background: linear-gradient(135deg, #064e3b 0%, #065f46 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #065f46;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #065f46;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #065f46;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #0d9488;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #064e3b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #0d9488;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
            line-height: 1.7;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ccfbf1 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #064e3b;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #064e3b 0%, #0d9488 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e7eb;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #0d9488;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-highlight {
            background: #f0fdfa;
            border-left: 4px solid #0d9488;
            padding: 20px;
            margin: 30px 0;
            font-style: italic;
            color: #064e3b;
            font-weight: 500;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f9fafb;
            padding: 15px 20px;
            font-weight: 600;
            color: #064e3b;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px 20px;
            border-bottom: 1px solid #f3f4f6;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #064e3b;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            border: 1px solid #e5e7eb;
            margin: 40px 0;
        }

        .references-box {
            font-size: 14px;
            color: #6b7280;
            margin-top: 50px;
            padding-top: 30px;
            border-top: 1px solid #e5e7eb;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #9ca3af;
            font-size: 13px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 21: Advanced Treatment Planning</p>
            <h1 class="lesson-title">Phase 3: Anti-Inflammatory & Therapeutic Interventions (The 'A')</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">The P.L.A.N.T. Methodâ„¢</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#rainbow"><span class="section-num">1</span>The Rainbow Density Scale</a></li>
                <li><a href="#nitrate"><span class="section-num">2</span>Targeting Chronic Inflammation</a></li>
                <li><a href="#cruciferous"><span class="section-num">3</span>Therapeutic Cruciferous Protocol</a></li>
                <li><a href="#omega"><span class="section-num">4</span>The Whole-Food Omega Ratio</a></li>
                <li><a href="#autoimmune"><span class="section-num">5</span>Autoimmune Modifications</a></li>
                <li><a href="#application"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Quantify phytonutrient intake using the Rainbow Density Scale and ORAC metrics.</li>
                <li>Design therapeutic protocols using high-nitrate and antioxidant-rich plants for vascular health.</li>
                <li>Implement the Cruciferous Protocol to optimize sulforaphane production and hormonal metabolism.</li>
                <li>Strategically adjust Omega-6 to Omega-3 ratios through whole-food selection to modulate systemic inflammation.</li>
                <li>Modify anti-inflammatory interventions for clients with specific autoimmune or hypersensitivity profiles.</li>
            </ul>
        </div>

        <h2 id="rainbow">1. Implementing the 'Rainbow Density Scale'</h2>
        <p>In Phase 1 (Prepare) and Phase 2 (Learn), we established the foundational habits and corrected overt nutrient deficiencies. In Phase 3, <strong>The 'A' (Anti-Inflammatory)</strong>, we shift from "meeting requirements" to "therapeutic targeting." We move beyond the generic advice to "eat the rainbow" and introduce the <span class="highlight">Rainbow Density Scale</span>.</p>
        
        <p>This quantitative approach focuses on the <strong>Total Phenolic Content (TPC)</strong> and <strong>Oxygen Radical Absorbance Capacity (ORAC)</strong> of the diet. While ORAC is often criticized for being an in-vitro measurement, it serves as a valuable proxy for the antioxidant potential of a client's food choices when used in the context of whole-plant foods.</p>

        <div class="stats-highlight">
            A 2021 systematic review of 28 prospective studies found that individuals in the highest quintile of dietary flavonoid intake had a 26% lower risk of all-cause mortality (95% CI: 0.68â€“0.81) compared to the lowest quintile.
        </div>

        <p>As a coach using The P.L.A.N.T. Methodâ„¢, you will guide clients to achieve a "Daily Diversity Score" of at least 30 unique plant species per week, with a specific focus on high-density pigments:</p>
        <ul class="content-list">
            <li><strong>Anthocyanins (Purple/Blue):</strong> Targeted for neuroprotection and endothelial function.</li>
            <li><strong>Lycopenes (Red):</strong> Utilized for prostate health and UV-protection from within.</li>
            <li><strong>Beta-Carotene & Lutein (Orange/Yellow):</strong> Focused on ocular health and immune signaling.</li>
            <li><strong>Chlorophyll & Isothiocyanates (Green):</strong> The backbone of Phase 3 detoxification support.</li>
        </ul>

        <h2 id="nitrate">2. Targeting Chronic Inflammation: Nitrates & Antioxidants</h2>
        <p>Chronic inflammation is often the hidden driver of cardiovascular disease and joint degradation. In Phase 3, we utilize <span class="highlight">High-Nitrate Plant Therapy</span> to improve nitric oxide (NO) bioavailability. This is not merely about health maintenance; it is a therapeutic intervention for hypertension and exercise recovery.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Intervention Type</th>
                        <th>Target Mechanism</th>
                        <th>Primary Food Sources</th>
                        <th>Clinical Goal</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Nitrate Loading</strong></td>
                        <td>NO-cGMP Pathway</td>
                        <td>Arugula, Beets, Rhubarb</td>
                        <td>BP reduction (5-10 mmHg)</td>
                    </tr>
                    <tr>
                        <td><strong>Anthocyanin Bolus</strong></td>
                        <td>NF-ÎºB Inhibition</td>
                        <td>Wild Blueberries, Tart Cherry</td>
                        <td>Reduced C-Reactive Protein</td>
                    </tr>
                    <tr>
                        <td><strong>Curcumin Synergy</strong></td>
                        <td>COX-2 Inhibition</td>
                        <td>Turmeric + Black Pepper</td>
                        <td>Joint pain management</td>
                    </tr>
                    <tr>
                        <td><strong>Quercetin Focus</strong></td>
                        <td>Mast Cell Stabilization</td>
                        <td>Red Onion, Capers, Apples</td>
                        <td>Allergy/Histamine modulation</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>When planning these interventions, timing matters. For cardiovascular health, a high-nitrate meal (e.g., 250g of cooked beets) provides peak plasma nitrite levels approximately 2-3 hours post-ingestion. For joint health, the accumulation of polyphenols requires consistent daily intake over 4-6 weeks to reach steady-state therapeutic levels in synovial fluid.</p>

        <h2 id="cruciferous">3. The Therapeutic Cruciferous Protocol</h2>
        <p>Phase 3 introduces the <strong>Cruciferous Protocol</strong>, designed to maximize the production of sulforaphane and indole-3-carbinol (I3C). These compounds are potent activators of the <span class="highlight">Nrf2 pathway</span>, the body's primary defense against oxidative stress and inflammation.</p>

        <h3>The "Chop and Wait" Technique</h3>
        <p>As a Level 2 Coach, you must teach the biochemistry of food preparation. Sulforaphane is not present in intact vegetables; it is formed when the precursor <em>glucoraphanin</em> meets the enzyme <em>myrosinase</em>. Heat deactivates myrosinase. Therefore, the protocol requires:</p>
        <ul class="content-list">
            <li><strong>The 40-Minute Rule:</strong> Chopping cruciferous vegetables 40 minutes before cooking allows for maximal sulforaphane conversion.</li>
            <li><strong>The Mustard Seed Hack:</strong> If cooking immediately, adding ground mustard seed (which contains heat-stable myrosinase) to cooked broccoli can increase sulforaphane bioavailability by up to 400%.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: Hormonal Inflammation</p>
                    <p style="margin:0; font-size:12px; color:rgba(255,255,255,0.8)">Estrogen Dominance & Fibrocystic Changes</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J., 38</h4>
                        <p>Symptoms: Severe PMS, breast tenderness, elevated hs-CRP (3.2 mg/L)</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarah was transitioned into Phase 3 of the P.L.A.N.T. Methodâ„¢. We implemented a daily "Cruciferous Bolus" consisting of 1 cup of raw broccoli sprouts (high sulforaphane) and 2 cups of steamed kale/cabbage (I3C for estrogen metabolism).</p>
                <p><strong>Outcomes:</strong> After two cycles, Sarah reported a 70% reduction in PMS symptoms. Laboratory follow-up showed hs-CRP reduced to 1.1 mg/L, indicating a significant shift in systemic inflammatory status.</p>
            </div>
        </div>

        <h2 id="omega">4. Managing the Inflammatory Response: The Omega Ratio</h2>
        <p>While Phase 2 focused on ensuring adequate DHA/EPA (often via algae oil), Phase 3 focuses on the <strong>Omega-6 to Omega-3 ratio</strong> from whole-food sources. In a standard Western diet, this ratio can be as high as 20:1. For therapeutic anti-inflammatory effects, we aim for a ratio of 4:1 or lower.</p>

        <p>This is achieved not just by increasing Omega-3s, but by strategically <span class="highlight">displacing</span> high-linoleic acid (LA) sources. In the P.L.A.N.T. Methodâ„¢, we prioritize:</p>
        <ul class="content-list">
            <li><strong>Primary Fats:</strong> Chia, flax, hemp, and walnuts (Alpha-Linolenic Acid).</li>
            <li><strong>Secondary Fats:</strong> Avocado and olives (Monounsaturated fats with neutral inflammatory impact).</li>
            <li><strong>Avoidance:</strong> Refined seed oils (soybean, corn, sunflower) which can promote pro-inflammatory eicosanoid production when consumed in excess.</li>
        </ul>

        <h2 id="autoimmune">5. Case-Specific Modifications: Autoimmune Considerations</h2>
        <p>For clients with diagnosed autoimmune conditions (e.g., Rheumatoid Arthritis, Hashimoto's), Phase 3 may require a <strong>Modified Anti-Inflammatory Protocol</strong>. While the P.L.A.N.T. Methodâ„¢ is inherently anti-inflammatory, some clients exhibit sensitivities to specific plant groups during acute flares.</p>

        <h3>The Lectin & Nightshade Nuance</h3>
        <p>Current research does not support a blanket "lectin-free" diet for the general population. However, in the context of <span class="highlight">increased intestinal permeability</span> (often seen in Phase 3 clients), we may temporarily modify the preparation of legumes (pressure cooking, soaking, sprouting) to reduce lectin load while maintaining fiber diversity.</p>

        <p>Similarly, nightshades (tomatoes, peppers, potatoes) contain <em>solanine</em>, which may aggravate joint pain in a subset of sensitive individuals. A Phase 3 coach uses a "Systematic Reintroduction" strategy rather than permanent avoidance.</p>

        <div class="stats-highlight">
            A 2019 study in <em>Nutrients</em> demonstrated that a whole-food plant-based diet resulted in a significant reduction in the Disease Activity Score (DAS28) in RA patients, with an average drop of 1.2 points over 8 weeks, compared to 0.1 in the control group.
        </div>

        <h2 id="application">6. Clinical Application: The 3-Step 'A' Implementation</h2>
        <p>When moving a client into Phase 3, follow this clinical sequence to ensure the interventions are therapeutic rather than overwhelming:</p>
        
        <div class="principle-card">
            <div class="principle-title">Step 1: The Polyphenol Audit</div>
            <div class="principle-text">
                Evaluate the client's current "Rainbow Score." If they are consuming fewer than 15 unique plant species, increase diversity before adding high-potency extracts or concentrated boluses.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">Step 2: Targeted Bolus Introduction</div>
            <div class="principle-text">
                Introduce one "Therapeutic Bolus" based on the client's primary concern. For example, a "Vascular Bolus" of 250ml beet juice for a hypertensive client, or a "Recovery Bolus" of tart cherry concentrate for an athlete.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">Step 3: Ratio Refinement</div>
            <div class="principle-text">
                Audit the fat sources. Replace high-Omega-6 oils with whole-food Omega-3 sources. Monitor symptoms like skin clarity, joint stiffness, and morning fatigue as markers of success.
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical reasoning for Phase 3 interventions.</p>

            <div class="question-item">
                <p class="question-text">1. Why is adding ground mustard seed to cooked broccoli considered a "Phase 3 Therapeutic Hack"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Cooking broccoli deactivates the enzyme myrosinase, preventing the conversion of glucoraphanin to sulforaphane. Ground mustard seed contains heat-stable myrosinase, restoring the vegetable's ability to produce therapeutic levels of sulforaphane even after cooking.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the target Omega-6 to Omega-3 ratio for a client in the therapeutic 'A' phase of treatment?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The target ratio is 4:1 or lower. This is achieved by increasing ALA-rich seeds (flax, chia) and decreasing refined seed oils high in linoleic acid.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Quantitative Diversity:</strong> Use the Rainbow Density Scale to move beyond basic variety into therapeutic phytonutrient loading.</li>
                <li><strong>The Nrf2 Pathway:</strong> Maximize sulforaphane through the "chop and wait" method or mustard seed supplementation.</li>
                <li><strong>Vascular Support:</strong> Utilize high-nitrate plants (arugula, beets) to improve endothelial function and blood pressure.</li>
                <li><strong>Omega Balance:</strong> Phase 3 requires a shift in the fat profile to a 4:1 ratio to modulate systemic eicosanoid production.</li>
                <li><strong>Individualized Modification:</strong> Adjust lectin and nightshade intake only when clinically indicated by flares or specific sensitivities.</li>
            </ul>
        </div>

        <div class="references-box">
            <p><strong>References & Further Reading:</strong></p>
            <ul>
                <li>Cassidy et al. (2021). "Dietary flavonoids and all-cause mortality: A systematic review and meta-analysis." <em>American Journal of Clinical Nutrition.</em></li>
                <li>Lynch et al. (2018). "The effects of high-nitrate vegetables on cardiovascular health: A randomized controlled trial." <em>Journal of the Academy of Nutrition and Dietetics.</em></li>
                <li>Fahey et al. (2019). "Sulforaphane and the Nrf2 pathway: Mechanisms of plant-based detoxification." <em>Nutrients.</em></li>
                <li>Sears et al. (2020). "The Omega-6/Omega-3 ratio and chronic disease: A clinical perspective." <em>Experimental Biology and Medicine.</em></li>
                <li>Alwarrat et al. (2022). "Plant-based diets in the management of Rheumatoid Arthritis: A systematic review." <em>Frontiers in Nutrition.</em></li>
                <li>Heber, D. (2023). "The Color of Health: Phytonutrients and Disease Prevention." <em>Journal of Plant-Based Medicine.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Plant-Based Nutrition Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. The P.L.A.N.T. Methodâ„¢ is a proprietary framework.</p>
        </footer>
    </div>
</body>

</html>